Watch Covid-19: Novavax (NVAX US) Surges on $1.2 Billion Sanofi Vaccine Deal - Bloomberg

May 10th, 2024

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

Novavax shares soared after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Madison Muller reports on Bloomberg Television.

Top Video

Duration:1:39

Trump Says He Didn't Ask Xi For Any Favors on Iran

Duration:3:29

Trump-Xi Summit: What Was Discussed

Duration:9:48

Burns on Key Takeaways From the Trump-Xi Summit

Bloomberg Brief

Duration:0:30

Trump Says China Will Buy Over 200 Boeing Planes

Duration:4:00

Xi Hails ‘Landmark’ Summit as Trump Departs

Duration:0:43

Trump Says He Spoke to Xi About Guardrails for AI

Duration:2:53

Trump Says China Offered Help With Iran Negotiations

Duration:3:45

Comparing China and US Statements on Trump-Xi Summit

The China Show

Available on:

Listen onApple TV Listen onRoku Listen onSamsung TV Listen onFire TV Listen onAndroid TV Listen onRakuten TV Listen onHaystack News

Watch BTV in your area: